<DOC>
	<DOCNO>NCT02635438</DOCNO>
	<brief_summary>The objective study compare efficacy safety Clotrimazole troche/ lozenges USP , 10 mg ( Unique Pharmaceutical Laboratories , India ) vs. Clotrimazole Troche/ Lozenges USP , 10 mg ( Roxane Laboratories Inc. , USA ) patient oropharyngeal candidiasis , condition diagnose clinical examination confirm fungal culture</brief_summary>
	<brief_title>A Comparative Clinical Trial Evaluate Safety Clinical Equivalence Clotrimazole Troche/Lozenges USP , 10mg ( Unique Pharmaceutical Laboratories , India ) With Clotrimazole Troche 10mg ( Roxane Laboratories Inc. , USA ) Subjects With Oropharyngeal Candidiasis .</brief_title>
	<detailed_description>This study Randomized , Double Blind , Parallel , Comparative study . Approximately 26 study site across India participate study complete sample size 360 randomize subject order achieve least 250 per-protocol ( PP ) subject . Subjects would assign randomly test product reference product 1:1 ratio . Subjects confirm oral candidiasis KOH smear/candidal culture give study medication 5 time day 14 consecutive day . The schedule subject 's visit study site follow : 1 . Visit 1 - Screening visit ( -7 Days ) . 2 . Visit 2 - Randomization ( Day 1 ) . 3 . Visit 3 - Follow Up ( Day 8 ( +2 ) ) . 4 . Visit 4 - Follow Up ( Day 15 ( +2 ) ) . 5 . Visit 5 - Follow Up/ End study ( Day 21 ( +/-4 ) ) Subjects complete resolution sign symptom Oral Candidiasis Day 21 ( +/-4 ) consider treatment success .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<criteria>1 . Presence specific sign symptom Oropharyngeal Candidiasis , include erythematous area , white patch ( thrush ) , mouth pain , irritation , burning , glossitis , alter taste , pruritis , dysphagia odynophagia . 2 . Clinical examination oropharynx consistent diagnosis oral candidiasis ( creamy , white , curdlike patch `` thrush '' erythematous lesion mucosal surface ) . 3 . Confirmation Candidiasis finding direct microscopic examination ( potassium hydroxide smear ) consistent Candida specie positive fungal culture Candida specie , culture obtain 2 day precede initiation therapy study drug . 4 . Subjects able willing give Informed Consent . 1 . Female subject pregnant , lactate plan become pregnant study period . 2 . Subjects diagnose disseminated candidiasis require systemic antifungal therapy . 3 . Subjects diagnose hairy leukoplakia . 4 . Presence perioral lesion , e.g. , angular chelitis . 5 . History intolerance sensitivity clotrimazole ( imidazole azole compound ) constituent Roxane Â® generic Clotrimazole Troche/ Lozenges unable tolerate oral medication . 6 . Subjects history resistance treatment clotrimazole ( Subject resistant Clotrimazole culture sensitivity test exclude study ) . 7 . Subjects receive oral systemic antifungal therapy within fourteen ( 14 ) day prior randomization . 8 . Subjects receive investigational therapy within 30 day prior randomization . 9 . Subjects diagnose concomitant condition , opinion investigator , could interfere evaluation efficacy safety , would make unlikely subject would complete study . 10 . Subjects treat protease inhibitor first time within 30 day . 11 . Subjects take medication know significant interaction azoles ( e.g. , antacid , H2receptor blocker , rifampin , phenytoin , carbamazepine , astemizole ) . 12 . Subjects history candidal prophylaxis azole antifungal medication . 13 . Any subject recurrent Oropharyngeal Candidiasis . 14 . Any subject chronically infected Candida . 15 . Any subject baseline liver function test great 3 time upper limit normal ( ULN ) . 16 . CD4 cell count le 200 cells/mm3 . 17 . Absolute neutrophil count less 500/mm3 . 18 . Subject history Type II Diabetes Mellitus Uncontrolled Blood Sugar level . ( I.e . Random Blood Sugar level &gt; 350 ) . 19 . Suspected inability ( ) unwillingness comply study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Oropharyngeal Candidiasis</keyword>
</DOC>